Paksoy, N. Et Al. 2022. Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, no.4 , 478-483.

Paksoy, N., Ferhatoglu, F., DOĞAN, İ., Khanmammadov, N., Bozbey, H. U., KARABULUT, S., ... Tastekin, D.(2022). Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study. TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, no.4, 478-483.

Paksoy, Nail Et Al. "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study," TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, no.4, 478-483, 2022

Paksoy, Nail Et Al. "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study." TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, no.4, pp.478-483, 2022

Paksoy, N. Et Al. (2022) . "Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study." TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY , vol.37, no.4, pp.478-483.

@article{article, author={Nail PAKSOY Et Al. }, title={Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study}, journal={TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY}, year=2022, pages={478-483} }